CALYPTE BIOMEDICAL CORPORATION Alameda, CA 94502 December 19, 2001Calypte Biomedical Corp • March 11th, 2002 • Laboratory analytical instruments • California
Upon your signature at the end of this letter where indicated, this letter will be the binding agreement (the “Agreement”), effective as of October 19, 2001 (the “Effective Date”), between Calypte Biomedical Corporation (“Calypte”) and you with respect to your provision of service as a consultant to Calypte as provided in this letter. The Basic Retained Services described in Section 1(a) hereof and any Additional Services defined in Section 1(b) hereof are referred to herein collectively as the “Services”.
THIRD ADDENDUM TO LEASEThird Addendum to Lease • March 11th, 2002 • Calypte Biomedical Corp • Laboratory analytical instruments
THIS THIRD ADDENDUM TO LEASE (“Third Addendum”) is made and entered into as of this 31st day of October, 2001, by and between GEE ASPORA LLC, a California limited liability company (“Landlord”), and CALYPTE BIOMEDICAL CORPORATION, a Delaware corporation (“Tenant”).
CALYPTE BIOMEDICAL CORPORATION COMMON STOCK PURCHASE AGREEMENT November 13, 2001Purchase Agreement • March 11th, 2002 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware
This Agreement (“Agreement”) is made as of November 13, 2001 (the “Execution Date”), by and among Calypte Biomedical Corporation, a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto. Such persons and entities are hereinafter collectively referred to herein as “Purchasers” and each individually as a “Purchaser.”
CALYPTE BIOMEDICAL CORPORATION COMMON STOCK PURCHASE AGREEMENTPurchase Agreement • March 11th, 2002 • Calypte Biomedical Corp • Laboratory analytical instruments • Delaware
This Agreement (“Agreement”) is made as of , 200_ (the “Execution Date”), by and among Calypte Biomedical Corporation, a Delaware corporation (the “Company”), and , a creditor of the Company (the “Purchaser”).
